3M Co. Stock Down 5% On Quarterly Results

Pre-market Movers: SPCB, SATX, HPK, MNPR, TENX…

The following are some of the stocks making big moves in Tuesday’s pre-market trading (as of 06.45 A.M. ET).

In the Green

SuperCom Ltd. (SPCB) is up over 20% at $2.75.
HighPeak Energy, Inc. (HPK) is up over 15% at $31.02.
Monopar Therapeutics Inc. (MNPR) is up over 12% at $3.63.
Vir Biotechnology, Inc. (VIR) is up over 6% at $30.99.

In the Red

Satixfy Communications Ltd. (SATX) is down over 17% at $5.99.
Tenax Therapeutics, Inc. (TENX) is down over 12% at $2.26.
PennantPark Floating Rate Capital Ltd. (PFLT) is down over 6% at $11.09.

European Economic News Preview: Eurozone Flash PMI Data Due

Flash Purchasing Managers’ survey results from the euro area and the UK are the top economic news due on Tuesday.

At 2.00 am ET, the Office for National Statistics releases UK public sector finance data. The budget deficit is seen widening to GBP 22.3 billion in December from GBP 21.2 billion in November.

In the meantime, Germany GfK consumer confidence survey results are due. The forward-looking sentiment index is seen improving to -33.0 in February from -37.8 in January.

At 2.45 am ET, France’s statistical office INSEE is scheduled to publish business sentiment survey results. The confidence index is expected to rise to 102 in January from 101 in the prior month.

At 3.15 am ET, S&P Global is scheduled to release France composite Purchasing Managers’ survey data. The composite PMI is expected to rise to 49.5 in January from 49.1 in the prior month.

At 3.30 am ET, Germany’s flash composite PMI data is due. The composite output index is seen at 49.6 in January versus 49.0 a month ago.

Half an hour later, Eurozone flash composite PMI survey results are due. Economists forecast the composite index to improve to 49.8 from 49.3 in the previous month.

At 4.30 am ET, UK S&P/CIPS composite PMI data is due. The index is expected to improve to 49.3 in January from 49.0 in December.

At 6.00 am ET, the Confederation of British Industry releases Industrial Trends survey results. The order book balance is seen at -8 in January versus -6 in December.

Paccar Inc. Bottom Line Rises In Q4

Paccar Inc. (PCAR) revealed a profit for its fourth quarter that increased from the same period last year

The company’s earnings came in at $921.3 million, or $2.64 per share. This compares with $518.7 million, or $1.49 per share, in last year’s fourth quarter.

The company’s revenue for the quarter rose 22.9% to $7.73 billion from $6.29 billion last year.

Paccar Inc. earnings at a glance (GAAP) :

-Earnings (Q4): $921.3 Mln. vs. $518.7 Mln. last year.
-EPS (Q4): $2.64 vs. $1.49 last year.
-Revenue (Q4): $7.73 Bln vs. $6.29 Bln last year.

Union Pacific Corp. Q4 Profit misses estimates

Union Pacific Corp. (UNP) released earnings for fourth quarter that missed the Street estimates.

The company’s earnings came in at $1.64 billion, or $2.67 per share. This compares with $1.71 billion, or $2.66 per share, in last year’s fourth quarter.

Analysts on average had expected the company to earn $2.78 per share, according to figures compiled by Thomson Reuters. Analysts’ estimates typically exclude special items.

The company’s revenue for the quarter rose 7.9% to $6.18 billion from $5.73 billion last year.

Union Pacific Corp. earnings at a glance (GAAP) :

-Earnings (Q4): $1.64 Bln. vs. $1.71 Bln. last year.
-EPS (Q4): $2.67 vs. $2.66 last year.
-Analyst Estimates: $2.78
-Revenue (Q4): $6.18 Bln vs. $5.73 Bln last year.

Missing Indigenous Persons Alert issued for Navajo teen

Denver police are searching for a 15-year-old Navajo boy who was last seen Monday evening.

Kaleb Waid, a 105-pound, five-foot-six-inch teen with brown hair and brown eyes, was last seen about 7:30 p.m. at Dahlia Street and 14th Avenue in Denver. He was last seen wearing a black shirt, gray sweater, black pants, a bejeweled belt and white shoes.

Anyone who may have seen Kaleb is asked to call 911 or the Denver Police Department at 720-913-2000.

Baudax Bio Spikes On Positive Phase Trial Results For BX1000

Baudax Bio, Inc. (BXRX) shares are surging more than 58 percent on Tuesday morning trade after the company announced positive results from the phase 2 double-blind, randomised trial for BX1000 for neuromuscular blockade in patients undergoing elective surgery.

Currently, shares are at $5.02, up 59.42 percent from the previous close of $3.15 on a volume of 29,113,498.

Altamira: NASAR Interim Analysis Shows Superior Efficacy Of Bentrio In Seasonal Allergic Rhinitis

Altamira Therapeutics Ltd. (CYTO) issued an update on the clinical trials with Bentrio in seasonal allergic rhinitis and acute COVID-19. The interim analysis of Australian NASAR trial in seasonal allergic rhinitis showed statistically significant improvement with Bentrio in nasal symptom primary endpoint over saline nasal spray comparator. The interim analysis also showed good tolerability and safety both for Bentrio and the comparator.

“Although the COVAMID study did not reach the primary efficacy endpoint, we observed a trend for faster and more pronounced reduction in the nasal viral load, which was corroborated by a similar trend in COVID-19 related symptoms,” said Thomas Meyer, CEO.

For More Such Health News, visit rttnews.com.

3M Co. Stock Down 5% On Quarterly Results

Shares of 3M Company (MMM) are slipping over 5% on Tuesday morning after the company reported fourth-quarter profit that dropped significantly from last year. The industrial behemoth also plans to cut 2,500 manufacturing jobs as demand for certain of its products slows down.

MMM is currently trading at $115.90, down $6.72 or 5.48%, on the NYSE. The stock opened its trading at $120.61 after closing previous day’s trading at $122.62. The stock has traded between $107.07 and $175.25 in the past 52-week period.

3M’s fourth-quarter profit dropped to $541 million or $0.98 per share from $1.34 billion or $2.31 per share last year.

Adjusted earnings were $1.26 billion, down $2.28 per share for the period. Analysts estimated earnings of $2.36 per share, according to figures compiled by Thomson Reuters. Analysts’ estimates typically exclude special items.

Revenues for the quarter slipped to $8.08 billion from $8.61 billion last year.